During the last session, Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares were 0.53 million, with the beta value of the company hitting 1.60. At the end
Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares stood at 1.05 million during the last session, with the company’s beta value hitting 1.62. At the close of
Elevation Oncology Inc (NASDAQ:ELEV) has a beta value of 1.45 and has seen 2.68 million shares traded in the last trading session. The company, currently
During the recent session, Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares were 0.58 million, with the beta value of the company hitting 1.45. The 52-week high
In the last trading session, 1.17 million Elevation Oncology Inc (NASDAQ:ELEV) shares changed hands as the company’s beta touched 1.57. With the company’s per share
In recent trading session, Elevation Oncology Inc (NASDAQ:ELEV) saw 0.45 million shares changing hands at last check today with its beta currently measuring 1.67. Company’s
Elevation Oncology Inc (NASDAQ:ELEV) has a beta value of 1.68 and has seen 1.58 million shares traded in the last trading session. The ELEV stock
Elevation Oncology Inc (NASDAQ:ELEV) has a beta value of 1.62 and has seen 1.75 million shares traded in the last trading session. The ELEV stock
In the last trading session, 1.79 million shares of the Elevation Oncology Inc (NASDAQ:ELEV) were traded, and its beta was 1.59. Most recently the company’s
In the last trading session, 4.14 million shares of the Elevation Oncology Inc (NASDAQ:ELEV) were traded, and its beta was 1.62. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
